Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 9, Number 8—August 2003

Research

Multidrug-Resistant Tuberculosis in HIV-Negative Patients, Buenos Aires, Argentina

Domingo Palmero*Comments to Author , Viviana Ritacco†, Martha Ambroggi‡, Marcela Natiello‡, Lucía Barrera†, Lilian Capone‡, Alicia Dambrosi‡, Martha Di Lonardo‡, Nélida Isola‡, Susana Poggi‡, Marisa Vescovo‡, and Eduardo Abbate‡
Author affiliations: *Hospital F. J. Muñiz, Buenos Aires, Argentina; †National Institute of Infectious Diseases “Carlos G. Malbran,” Buenos Aires, Argentina; ‡University of Buenos Aires, Buenos Aires, Argentina

Main Article

Figure 3

Biennial number of initial multidrug-resistant tuberculosis cases among HIV-negative patients and restriction fragment length polymorphism findings. RFLP, restriction fragment length polymorphism.

Figure 3. Biennial number of initial multidrug-resistant tuberculosis cases among HIV-negative patients and restriction fragment length polymorphism findings. RFLP, restriction fragment length polymorphism.

Main Article

Top of Page

 

Past Issues

Select a Past Issue:

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO